SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
cei12388-sup-0001-si.pdf1676K

Fig S1. Intra-assay coefficient of variation (intra-CV) of time of maximal convertase activity (Tmax) curves. Tmax curve for classical pathway (left panel) and alternative pathway (right panel) was calculated from four repetitions. Classical pathway convertase was formed from 0.5% normal human serum (NHS) blocked with 12.5 nM Ornithodoros moubata complement inhibitor (OmCI) or 2 nM eculizumab. Alternative pathway convertase was formed from 5% NHS blocked with 100 nM OmCI or 60 nM eculizumab.

Table S1. Detailed characteristics of clinical samples used in the study.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.